Antibodies News and Research

RSS

Man takes 217 COVID vaccines with no ill effects, shows immune boost

A case report of a 62-year-old man receiving 217 SARS-CoV-2 vaccinations over 29 months reveals no adverse effects, increased T-cells, and spike-specific antibodies, providing unique insights into the effects of hyper-vaccination on immune responses.

7 Mar 2024

COVID-19 booster enhances virus neutralizing antibodies in breast milk, new study reveals

The potential of COVID-19 booster vaccine products (antibodies) passed from mother to offspring through breastmilk.

7 Mar 2024

Study reveals nerve changes linked to pain and urinary frequency in recurrent UTI sufferers

How sensory nerve sprouting and mast cell activity, driven by nerve growth factor (NGF), contribute to persistent bladder pain and dysfunction in recurrent urinary tract infection (rUTI) cases.

7 Mar 2024

Researchers examine the immune response of a hypervaccinated individual

Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen have examined a man who has received more than 200 vaccinations against Covid-19. They learned of his case via newspaper reports.

5 Mar 2024

COVID booster in lactating mothers can provide antibodies for infants

Lactating mothers who get the COVID-19 booster pass along the antibodies to their children via their breast milk – and potentially protect babies too young to receive the vaccine, a study from the University of Florida Institute of Food and Agricultural Sciences (UF/IFAS) and the UF College of Medicine found.

4 Mar 2024

Study reveals safety of MS drugs during breastfeeding in child's early years of life

Certain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child during the first three years of life, according to a preliminary study released today, March 4, 2024.

4 Mar 2024

COVID-19 linked to long-lasting cognitive deficits, study finds

Study in England suggests that COVID-19 may lead to long-term cognitive deficits, with more severe impacts observed in individuals infected early in the pandemic or with prolonged symptoms.

4 Mar 2024

Zika vaccine shows promise for protecting fetuses when administered during pregnancy

A vaccine against Zika virus is safe and effective when administered both before and during pregnancy, according to new research published in npj Vaccines.

4 Mar 2024

Unlocking the secrets of T follicular helper cells for better treatment strategies

T follicular helper cells (Tfh) are essential for strong antibody-mediated reactions of our immune system during infections and vaccinations. However, if they get out of control, this can cause diseases such as autoimmunity, allergies or cancer.

1 Mar 2024

Broad-spectrum neutralizing antibody mAb-39 targets conserved S2 epitope in SARS-CoV-2

The ongoing COVID-19 pandemic caused by SARS-CoV-2 has caused serious damage to public health and the global economy, and one strategy to combat COVID-19 has been the development of broadly neutralizing antibodies for prophylactic and therapeutic use.

1 Mar 2024

Newly identified antibodies target a hard-to-spot region of the influenza virus

Researchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored "dark side" of the neuraminidase (NA) protein head.

1 Mar 2024

Breakthrough blood test developed for early detection of sarcoidosis

A research project led by Lobelia Samavati, M.D., professor of internal medicine and molecular medicine and genetics at the Wayne State University School of Medicine, and supported by the National Institutes of Health (NIH), has developed a tool to rapidly and inexpensively diagnose sarcoidosis, a chronic inflammatory disease marked by the growth of tiny lumps called granulomas in the lungs and other organs.

28 Feb 2024

Sinusitis tied to elevated rheumatic disease risk

The common inflammatory condition sinusitis is linked to a 40% heightened risk of a subsequent diagnosis of rheumatic disease, particularly in the 5 to 10 years preceding the start of symptoms, finds research published in the open access journal RMD Open.

27 Feb 2024

Scientists uncover a new doorway for SARS-CoV-2 into human cells

Research identifies the human transferrin receptor as an alternative pathway for SARS-CoV-2 infection, offering potential new targets for COVID-19 therapies.

27 Feb 2024

Innovative therapy targets and destroys leukemia stem cells

Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States, have devised an innovative approach to target and destroy hard-to-kill leukemia stem cells.

26 Feb 2024

Structural study identifies target for broad-spectrum antivirals against herpesviruses

Human herpesviruses comprise the alpha, beta, and gamma subfamilies and are a widely prevalent group of DNA-enveloped viruses, capable of establishing lifelong latent infections in humans and causing various diseases.

26 Feb 2024

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

A study published in Immunity shows that antibody responses to SARS-CoV-2 infection and vaccination are long-lasting, with an initial decline followed by stabilization after seven to nine months, highlighting the effectiveness of mRNA vaccines and the importance of hybrid immunity.

25 Feb 2024

Antibodies News and Research

Man takes 217 COVID vaccines with no ill effects, shows immune boost

COVID-19 booster enhances virus neutralizing antibodies in breast milk, new study reveals

Study reveals nerve changes linked to pain and urinary frequency in recurrent UTI sufferers

Researchers examine the immune response of a hypervaccinated individual

COVID booster in lactating mothers can provide antibodies for infants

Study reveals safety of MS drugs during breastfeeding in child's early years of life

COVID-19 linked to long-lasting cognitive deficits, study finds

Zika vaccine shows promise for protecting fetuses when administered during pregnancy

Unlocking the secrets of T follicular helper cells for better treatment strategies

Broad-spectrum neutralizing antibody mAb-39 targets conserved S2 epitope in SARS-CoV-2

Newly identified antibodies target a hard-to-spot region of the influenza virus

Breakthrough blood test developed for early detection of sarcoidosis

Sinusitis tied to elevated rheumatic disease risk

Scientists uncover a new doorway for SARS-CoV-2 into human cells

Innovative therapy targets and destroys leukemia stem cells

Structural study identifies target for broad-spectrum antivirals against herpesviruses

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

Omalizumab shows promise in preventing food allergy reactions in children, study finds

Researchers develop promising recombinant flu vaccine using nanoliposome technology

Research reveals bacteria's dynamic defense duo against phage viruses

Antibodies eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News